HomeAI · summaries
Storia in 3 fonti
Vaccine designed to ‘intercept’ pancreatic cancer induces durable responses
An investigational vaccine that targets common KRAS mutations induced durable immune responses among individuals at high risk for pancreatic cancer, results of a phase 1 clinical trial showed.Eighteen of 20 participants achieved KRAS-specific T-cell responses. Several individuals had either complete radiographic resolution or regression of pancreatic cysts, and none developed pancreatic cancer by
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Sensitive blood test detects pancreatic cancer signs often missed by standard methods
A highly sensitive blood test can detect signs of pancreatic cancer that standard methods often miss, according to results of a prospective cohort study.Digital droplet polymerase…
- ·
Vaccine designed to ‘intercept’ pancreatic cancer induces durable responses
An investigational vaccine that targets common KRAS mutations induced durable immune responses among individuals at high risk for pancreatic cancer, results of a phase 1 clinical…
- ·
repubblica.it
Prevenire il tumore del pancreas con un vaccino: positivi i primi test sull’uomo
I primi risultati sulla sicurezza fanno ben sperare: “In 16,5 mesi nessuno si è ammalato e alcune lesioni sono regredite”
- ·
eluniverso.com
Vacuna experimental para prevenir el cáncer de páncreas ofrece una respuesta inmunitaria significativa
El producto generó respuestas inmunitarias duraderas destinadas a prevenir este tumor en personas con alto riesgo.